Heartflow, a cardiac CT AI vendor, files for a $100 million IPO after notable adoption and revenue growth.
Key Details
- 1Heartflow filed SEC documents for a $100M IPO following positive coverage news for its AI CT software.
- 2Radiology benefits manager EviCore and proposed Medicare Fee Schedule support are expected to boost future adoption.
- 3Heartflow's CT-based platform has been used on over 400,000 patients, including 132,000 last year.
- 4Company reported $126 million in revenue for 2023, up 44% year-over-year, but posted a $32.3 million quarterly loss in early 2024.
- 5Market opportunity for Heartflow's AI solutions estimated at $5 billion in the U.S. annually.
- 6IPO proceeds will be used for debt payment, sales, R&D, and general operations.
Why It Matters
Heartflow's IPO marks a major milestone in the maturation of radiology-focused AI companies and demonstrates growing clinical and payer acceptance of imaging AI tools. The public funding and Medicare consideration signal greater integration of AI in CT-based cardiovascular diagnostics.
Source
Radiology Business
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.